The invention relates to substituted alcohol compounds of the formula (I): ##STR1##

wherein X, R1, R2, R3, RN, R20 and RC are defined herein. The compounds are useful in the treatment or prevention of Alzheimer's disease and more specifically to compounds that are capable of inhibiting beta-secretase, an enzyme that cleaves amyloid precursor protein to produce amyloid beta peptide (A-beta), a major component of the amyloid plaques found in the brains of Alzheimer's sufferers.

 
Web www.patentalert.com

< HIV integrase inhibitors

< Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor

> Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof

> Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
~ 00230